< Back to situations

[ORGANIZATION]

JAMA Cardiology

Featured in 7 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [US] [EC] [VN]

Rising cardiovascular disease in young adults

7 clusters · 24 sources · last updated

Latest: Global Burden of Disease study highlights rising heart failure trends

Recent medical data indicates a significant rise in cardiovascular issues among younger populations. A study in the journal Neurology found that stroke rates for adults aged 20 to 54 nearly doubled between 1993 and 2020,

[ACTIVE] [HEALTH] [DE] [US]

Research on intensive blood pressure reduction

2 clusters · 4 sources · last updated

Latest: Intensive blood pressure treatment reduces cardiovascular risks

A meta-analysis of 27 studies involving approximately 90,000 participants indicates that intensive blood pressure reduction significantly lowers the risk of heart attacks and strokes. Research published in JAMA Cardiolog

[QUIET] [HEALTH] [US] [BR] [CN]

Health risks and physiological shifts associated with Menop

12 clusters · 80 sources · last updated

Latest: Menopause health: Experts address systemic impacts of hormonal changes

Research continues to establish links between the timing of menopause and long-term health risks. Previous studies identified that menopause before age 40 increases coronary heart disease risk by approximately 40% and is

[QUIET] [HEALTH] [AU] [ES] [GB]

Research on inflammation and physical frailty in health

2 clusters · 4 sources · last updated

Latest: Inflammation and physical decline linked to early cardiovascular risk

Medical research has increasingly identified connections between systemic inflammation, physical frailty, and various long-term health risks. Initial studies in Spain focused on how chronic immune activation, or ‘inflam

[QUIET] [HEALTH] [KR] [SE]

Atrial fibrillation stroke prevention and cognitive research

5 clusters · 10 sources · last updated

Latest: Oral anticoagulants studied for intermediate stroke risk in atrial fibrillation

Clinical research has increasingly supported the use of oral anticoagulants (OAC) for stroke prevention in patients with atrial fibrillation (AF) at intermediate risk. Data from the SINGLE-AF trial, published in The New

Also covered in